LexDanaLexDanabeta
Inventor

GRAZIELLA I. SHEVLIN

Inventor
PE

Overview

1→
Patents
2022
Patent span
Human necessities
Primary field (CPC A)

Patents· 1 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium25%
PatentTitleYear
11,292,796Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to SIGNAL PHARM LLC (1)· patent assignee history
2022Based in PE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SIGNAL PHARM LLC12022
Locations
LocationPatentsSpan
PE12022